Results 151 to 160 of about 37,805 (220)

Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progression. [PDF]

Front Immunol
Abrate C, Brunotto V, Bossio SN, Boccardo S, Tosello Boari J, Caudana P, Hernandez L, Gimenez C, Theumer MG, Sedlik C, Amezcua-Vesely MC, Robson SC, Gruppi A, Piaggio E, Acosta Rodríguez EV, Montes CL.   +15 more
europepmc   +1 more source

CD39 polymorphism enables lung thrombosis in sickle cell disease. [PDF]

Nat Commun
Brzoska T, Kaminski TW, Katoch O, Menchikova EV, Alagbe AE, Tashbook SE, Tofovic SP, Jonassaint JC, St Croix CM, Watkins SC, Howe S, Field JJ, Seyerle AA, Pradhan-Sundd T, Laurie C, Pankratz ND, Smith NL, Goode EL, Pankow JS, Kooperberg C, Kato GJ, Zhang Y, Novelli EM, Gladwin MT, Jackson EK, Nouraie SM, Sundd P.   +26 more
europepmc   +1 more source

CD39⁺PD-1⁺ regulatory T cells in melanoma: key drivers of systemic immunosuppression and prognostic biomarkers. [PDF]

Front Oncol
Qiao G, He H, Wang X.
europepmc   +1 more source

CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why? [PDF]

, 2006
Alison Grinthal, Guido Guidotti, A Rothstein, AU Ziganshin, M Handa, TF Wang, H Zimmermann, N Braun, JD Shi, F Bigonnesse, A Biederbick, G Semenza, RA North, L Plesner, TF Wang, CR Maliszewski, TF Wang, D Bermudes, J Schulte am Esch, P Bork, TM Smith, JH Drosopoulos, F Yang, A Grinthal, BP Chadwick, A Grinthal, P Heine, W Chen, BU Failer, AF Knowles, A Grinthal, AG Hughson, FF Hamdan, MW Bunn, A Papanikolaou, T Mukasa, JA Lundbaek, EM Schweibert, AJ Brake, G Burnstock, E Bodas, Y Wu   +41 more
core   +1 more source

Resistance exercise exerts anti-hypertensive effects and downregulates NTPDase/CD39 and ecto-5'-nucleotidase/CD73 expression in patients with chronic kidney disease undergoing hemodialysis. [PDF]

Purinergic Signal
Dalagnol AMK, Franscescon F, Bianchini MC, Puhle JG, da Silva KET, Santos HM, de Oliveira Maciel SFV, de Resende E Silva DT.   +7 more
europepmc   +1 more source

SNP rs10748643 determines CD39 expression in T and NK cells through altering NFIC binding affinity rather than interfering with RNA splicing. [PDF]

Front Immunol
Gan C, Wu Q, Goronzy JJ, Zhang Y, Li L, Sheng H, Fang F.   +6 more
europepmc   +1 more source

T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis

International Journal of Nanomedicine
Xiaoshan Yang,1– 3,* Yang Zhou,2,3,* Fuxing Zhou,4,* Lili Bao,2,3 Zhengyan Wang,5 Zihan Li,2,3 Feng Ding,2,3 Huijuan Kuang,6,7 Huan Liu,8 Shenglong Tan,1 Xinyuan Qiu,1 Huan Jing,9 Shiyu Liu,2,3 Dandan Ma1 1Department of Endodontics ...
Yang X, Zhou Y, Zhou F, Bao L, Wang Z, Li Z, Ding F, Kuang H, Liu H, Tan S, Qiu X, Jing H, Liu S, Ma D   +13 more
doaj  

Special Issue "Purinergic Signalling in Physiology and Pathophysiology 2.0". [PDF]

Int J Mol Sci
Sluyter R.
europepmc   +1 more source

Prognostic value of stromal CD39⁺CD8⁺ T cells in predicting platinum sensitivity and survival outcomes in epithelial ovarian cancer. [PDF]

Sci Rep
Sun HY, Kang S, Wu JL, Li XP, Liu YP, Li Y.   +5 more
europepmc   +1 more source

Anti-CD39 Monoclonal Antibody TTX-030 [PDF]

, 2020
openaire   +1 more source